Because NRP1 is able to enhance TGFβ signalling during liver fibrogenesis [10], we used ex vivo myofibroblast cultures combined with human scRNAseq data to assess whether this mechanism also contributed to CKD progression. Here, TGFB1 is linked to chronic kidney disease.